Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report

BACKGROUND: Although cyclophosphamide (CPA) is the key drug for the treatment of autoimmune diseases including vasculitides, it has some well-known adverse effects, such as myelosuppression, hemorrhagic cystitis, infertility, and infection. However, CPA-associated severe enteritis is a rare adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Hiroko, Shirai, Tsuyoshi, Fujii, Hiroshi, Ishii, Tomonori, Harigae, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160622/
https://www.ncbi.nlm.nih.gov/pubmed/34092982
http://dx.doi.org/10.3748/wjg.v27.i20.2657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160622/
https://www.ncbi.nlm.nih.gov/pubmed/34092982
http://dx.doi.org/10.3748/wjg.v27.i20.2657

Ejemplares similares